About the National Data

Data

Baseline: 46.6 percent of adults aged 18 years and over with chronic kidney disease had elevated blood pressure in 2013-16 (age adjusted to the year 2000 standard population)

Target: 42.8 percent

Numerator
Number of adults aged 18 years and over with chronic kidney disease stages 1–4 with measured high systolic (≥130 mmHg) or diastolic (≥80 mmHg) blood pressure.
Denominator
Number of adults aged 18 years and over with chronic kidney disease stages 1–4 who have blood pressure measurements.
Target-setting method

Minimal statistical significance

Target-setting method details
Minimal statistical significance, assuming the same standard error for the target as for the baseline.
Target-setting method justification
Trend data were not available for this objective. The standard error was used to calculate a target based on minimal statistical significance, assuming the same standard error for the target as for the baseline. This method was used because the target is a statistically significant improvement from the baseline. This conservative target was selected because of the lower threshold definition of high blood pressure in the more recent patient care recommendations.

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from HP2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People objective CKD-6.1 in that objective CKD-6.1 tracked persons with chronic kidney disease stages 1-4 with measured systolic (≥ 140 mmHg) or diastolic (≥ 90mmHg) blood pressure, while this objective tracks persons with chronic kidney disease stages who had measured systolic (≥ 130mmHg) or diastolic (≥ 80 mmHg) blood pressure

References

Additional resources about the objective

United States Renal Data System. 2018 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2018.